Professor of Medicine, Division of Gastroenterology; Regional Lead, Permanente Group Northern California Program in Inflammatory Bowel Disease Kaiser Permanante Northern California San Francisco, California
One of the most dreaded complications of inflammatory bowel disease, colorectal cancer is a leading cause of cancer-related deaths in men and women in the US. Thankfully, advancements in endoscopic technology and techniques are allowing for earlier detection of dysplasia, which is associated with an increased risk of CRC. This session will discuss recent recommendations related to dysplasia and colorectal cancer screening in patients with IBD.
Learning Objectives:
Discuss updated terminology to describe dysplasia
Review the key fundamentals for dysplasia detection in IBD
Understand the role of dye spray chromoendoscopy and virtual chromoendoscopy in the detection of dysplasia
Describe features of resectable dysplastic lesions in IBD
Understand the criteria for recommending surveillance colonoscopy intervals in patients with IBD